R01 CA167093/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2012	1
2014	1
2015	1
2016	1
2018	1
2019	1
2020	1
2022	1
2024	0

1

Disrupting the MYC-TFEB Circuit Impairs Amino Acid Homeostasis and Provokes Metabolic Anergy.

Fernandez MR, Schaub FX, Yang C, Li W, Yun S, Schaub SK, Dorsey FC, Liu M, Steeves MA, Ballabio A, Tzankov A, Chen Z, Koomen JM, Berglund AE, Cleveland JL. Fernandez MR, et al. Cancer Res. 2022 Apr 1;82(7):1234-1250. doi: 10.1158/0008-5472.CAN-21-1168. Cancer Res. 2022. PMID: 35149590 Free PMC article.

2

Tristetraprolin impairs myc-induced lymphoma and abolishes the malignant state.

Rounbehler RJ, Fallahi M, Yang C, Steeves MA, Li W, Doherty JR, Schaub FX, Sanduja S, Dixon DA, Blackshear PJ, Cleveland JL. Rounbehler RJ, et al. Cell. 2012 Aug 3;150(3):563-74. doi: 10.1016/j.cell.2012.06.033. Cell. 2012. PMID: 22863009 Free PMC article.

3

Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function.

Berglund AE, Scott KE, Li W, Yang C, Fernandez MR, Schaub FX, Cleveland JL, Rounbehler RJ. Berglund AE, et al. Oncotarget. 2016 Dec 13;7(50):83462-83475. doi: 10.18632/oncotarget.13128. Oncotarget. 2016. PMID: 27825143 Free PMC article.

4

Engineered BRET-Based Biologic Light Sources Enable Spatiotemporal Control over Diverse Optogenetic Systems.

Parag-Sharma K, O'Banion CP, Henry EC, Musicant AM, Cleveland JL, Lawrence DS, Amelio AL. Parag-Sharma K, et al. ACS Synth Biol. 2020 Jan 17;9(1):1-9. doi: 10.1021/acssynbio.9b00277. Epub 2019 Dec 17. ACS Synth Biol. 2020. PMID: 31834783 Free PMC article.

5

CREB targets define the gene expression signature of malignancies having reduced levels of the tumor suppressor tristetraprolin.

Fallahi M, Amelio AL, Cleveland JL, Rounbehler RJ. Fallahi M, et al. PLoS One. 2014 Dec 26;9(12):e115517. doi: 10.1371/journal.pone.0115517. eCollection 2014. PLoS One. 2014. PMID: 25541715 Free PMC article.

6

Tristetraprolin Is a Prognostic Biomarker for Poor Outcomes among Patients with Low-Grade Prostate Cancer.

Rounbehler RJ, Berglund AE, Gerke T, Takhar MM, Awasthi S, Li W, Davicioni E, Erho NG, Ross AE, Schaeffer EM, Klein EA, Karnes RJ, Jenkins RB, Cleveland JL, Park JY, Yamoah K. Rounbehler RJ, et al. Cancer Epidemiol Biomarkers Prev. 2018 Nov;27(11):1376-1383. doi: 10.1158/1055-9965.EPI-18-0369. Epub 2018 Aug 14. Cancer Epidemiol Biomarkers Prev. 2018. PMID: 30108099 Free PMC article.

7

Fluorophore-NanoLuc BRET Reporters Enable Sensitive In Vivo Optical Imaging and Flow Cytometry for Monitoring Tumorigenesis.

Schaub FX, Reza MS, Flaveny CA, Li W, Musicant AM, Hoxha S, Guo M, Cleveland JL, Amelio AL. Schaub FX, et al. Cancer Res. 2015 Dec 1;75(23):5023-33. doi: 10.1158/0008-5472.CAN-14-3538. Epub 2015 Sep 30. Cancer Res. 2015. PMID: 26424696 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Results by year